A Category of One
LOBO Technology
- High density, small pore structure for optimal flow obstruction
- Significantly reduces flow to accelerate hemostasis and thrombosis
- Fast and complete occlusion with a single device
- Highly stable after placement
- No spinnaker effect
*For illustrative purposes only.
Versatile Design
- Multiple-disc design to compound the occlusive effects of the HDBRAID technology
- Excellent trackability to small, tortuous vessels
- Focal and efficient occlusion
- Expands accessible anatomical locations
- Conformance to curved vessels
- Thoroughly tested for compatibility with multiple catheters on the market today
- Enables treatment of vessel ranges from 1.5mm to 9mm with just 4 sizes
- Produces minimal CT artifact
LOBO + SENDERO®
Next Generation of Vascular Occlusion
SENDERO Delivery Catheter is optimized for use with LOBO.
LOBO
SENDERO
Product Information
| Model Number | Target Vessel Diameter | Unconstrained Implant Diameter | Unconstrained Braid Length | Pusher Length | Delivery Catheter |
|---|---|---|---|---|---|
| LOBO-3 | 1.5 – 3.0 mm | 5 mm | 6 mm | 181 cm | SENDERO Microcatheter |
| LOBO-5 | 3.0 – 5.0 mm | 6.5 mm | 9.5 mm | 181 cm | SENDERO Microcatheter |
| LOBO-7 | 5.0 – 7.0 mm | 9.5 mm | 8.5 mm | 181 cm | SENDERO MAX |
| LOBO-9 | 7.0 – 9.0 mm | 12.5 mm | 12 mm | 181 cm | SENDERO MAX |
See Instructions for Use for a complete list of warnings, precautions, and contraindications.
Indications for Use
The Okami Medical LOBO Vascular Occlusion System is intended for use to obstruct or reduce the rate of blood flow in arteries of the peripheral vasculature. The device is not indicated for use in blood vessels where crush or bend forces are anticipated (e.g. joint areas, superficial vasculature).
The SENDERO Microcatheter is intended for the peripheral vasculature for the infusion of diagnostic and therapeutic agents. The SENDERO MAX Delivery Catheter is intended for the peripheral vasculature for the infusion of diagnostic and therapeutic agents.
Rx Only: Federal (USA) law restricts device to sale by or on the order of a physician.
MRI Safety Information
Non-clinical testing and MRI simulations were performed to evaluate the LOBO Vascular Occlusion Device. Non-clinical testing demonstrated that this product is MR Conditional. A patient with an implant can be scanned safely in an MR system under the following conditions:
Static magnetic field of 1.5-Tesla and 3-Tesla, only
Maximum spatial gradient magnetic field of 4,000-gauss/cm (40-T/m)
Maximum MR system reported, whole body averaged specific absorption rate (SAR) of 2-W/kg in the Normal Operating Mode
Under the scan conditions defined, an implant from the LOBO Vascular Occlusion Device is expected to produce a maximum temperature rise of 2˚C after 15-minutes of continuous scanning.
In non-clinical testing, the image artifact caused by the implant from the LOBO Vascular Occlusion Device extends approximately 5-mm from this device when imaged with a gradient echo pulse sequence and a 3-Tesla MR system.
Okami Medical Intellectual Property
The product(s) listed on this website, either alone or in combination with other product(s), may be protected by one or more of the identified U.S. patents. Each product may also be protected by one or more patents issued outside of the U.S., and additional patent applications related to one or more of the listed products may be pending in the U.S. or elsewhere. The absence of a product name or patent number associated with any listed product does not constitute a waiver of Okami Medical’s intellectual property rights concerning that product or patent. This website is intended to serve as notice under 35 U.S.C. § 287(a).
LOBO – U.S. Patents 10,376,267, 10,660,648 and 11,304,701.
LOBO Manufacturing – U.S. Patents 9,994,980, 10,577,733, 11,346,027, 11,885,051 and 11,898,282.
LOBO Delivery System – U.S. Patents 10,531,877 and 11,298,137.
Okami Medical, SENDERO and LOBO are registered trademarks of Okami Medical, Inc., HDBRAID is a registered trademark of Inceptus Medical LLC.
